Knowstox

Fundamentals snapshot

Lam Research Corporation

LRCX · NMS · Technology · Semiconductor Equipment & Materials

Current price

$324.45

52-week range

$87.02 - $346.19

Market cap

$405.75B

One-glance verdict

Overvalued

$72.95 vs market $324.45

Fair-value range $48.30 – $109.62 (cautious → optimistic — tap the ? for the math)

Wall Street consensus: $316.19 (333.4% higher than our fair-value estimate)

Buy below $58.36 for a 20% safety cushion

Balance sheet

Healthy

33.11x Strong cushion

Net cash $1.02B. Interest coverage shows how many times profit covers the interest bill.

What this company does

Lam Research Corporation

Lam Research makes the highly specialized, complex machines that other companies use to manufacture computer chips, the tiny electronic brains inside phones, cars, and computers. It earns money not just by selling these multi-million dollar tools, but also by servicing them and selling parts, creating a stream of recurring revenue (predictable income from ongoing services). Because nearly every advanced electronic device relies on chips, Lam's business is fundamental to the entire tech industry.

Price history

How the share price has moved

Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2024 Q4 $761.68M FY2025 Q1 $1.46B FY2025 Q2 $553.59M FY2025 Q3 $1.02B FY2025 Q4 $2.38B FY2026 Q1 $1.59B FY2026 Q2 $1.22B FY2026 Q3 $809.82M
Revenue $5.84B
Net income $1.83B
Diluted EPS 1.45
Operating cash flow $1.14B
Free cash flow $809.82M
Revenue $5.34B
Net income $1.59B
Diluted EPS 1.26
Operating cash flow $1.48B
Free cash flow $1.22B
Revenue $5.32B
Net income $1.57B
Diluted EPS 1.24
Operating cash flow $1.78B
Free cash flow $1.59B
Revenue $5.17B
Net income $1.72B
Diluted EPS 1.34
Operating cash flow $2.55B
Free cash flow $2.38B
Revenue $4.72B
Net income $1.33B
Diluted EPS 1.03
Operating cash flow $1.31B
Free cash flow $1.02B
Revenue $4.38B
Net income $1.19B
Diluted EPS 0.92
Operating cash flow $741.94M
Free cash flow $553.59M
Revenue $4.17B
Net income $1.12B
Diluted EPS 0.86
Operating cash flow $1.57B
Free cash flow $1.46B
Revenue $3.87B
Net income $1.02B
Diluted EPS 7.78
Operating cash flow $862.43M
Free cash flow $761.68M

Is it cheap or expensive?

Fair value $72.95 vs current price $324.45

Wall Street consensus is the average analyst price target: $316.19 (333.4% higher than our fair-value estimate).

Buy below $58.36 for a 20% safety cushion. That means buying at least 20% below our fair value, as a buffer in case our estimate turns out too rosy.

Our most-likely fair value is $72.95 a share — about 77.5% below today's price of $324.45, so the stock currently looks expensive (overvalued).

overvalued

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 11.0% · Discount 12.1% · Terminal 2.5%

$72.95

Bear

Growth 3.0% · Discount 12.1% · Terminal 2.5%

$48.30

Bull

Growth 19.0% · Discount 12.1% · Terminal 2.5%

$109.62

Is it drowning in debt?

Healthy

Net cash $1.0B - more cash than debt. Interest coverage 33.1x.

Net debt $-1.02B
Interest coverage 33.11x

Lam Research Corporation's profit covers its interest bill about 33.1 times over. which is stronger than most peers shown here.

Healthy
Worse cushion Baseline Better cushion
LRCX BASELINE Lam Research Corporation

Total debt $3.73B Interest coverage 33.11x This is the baseline the peer rows are being compared against.

Total debt $7.27B Interest coverage 31.49x -5% vs LRCX Has roughly the same debt cushion as LRCX.

Total debt $3.12B Interest coverage 95.53x +188% vs LRCX Carries about 2.9x more debt cushion than LRCX.

Total debt $6.15B Interest coverage 16.59x -50% vs LRCX Carries about 2.0x less debt cushion than LRCX.

Total debt $0.00 Interest coverage 317.98x +860% vs LRCX Carries about 9.6x more debt cushion than LRCX.

Total debt $83.10M Interest coverage 1,042.33x +3,048% vs LRCX Carries about 31.5x more debt cushion than LRCX.

What you should know

The case for and against LRCX

3 Rewards 1 Risk

Rewards

  • Revenue grew 17.6% last year.
  • Returns 66.8% on equity, ahead of 66% of its peers.
  • Free cash flow was positive in 10/10 years.

Risks

  • Stock trades 148.2% above its 5-year average P/E.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
57.42x
Forward P/E
40.85x
P/B
38.33x
P/S
18.71x
EV/EBITDA
51.57x
PEG ratio
1.77x

Profitability

How much profit each dollar creates

Gross margin
50.0%
Operating margin
35.0%
Net margin
30.9%
ROE
66.8%
ROA
22.8%

Health

Liquidity and balance-sheet strength

Debt / equity
0.35x
Current ratio
2.54x
Quick ratio
1.70x
Total debt
$3.73B
Total cash
$4.75B

Growth

How the business has been compounding

Revenue TTM
$21.68B
Revenue 5Y CAGR
6.0%
EPS TTM
5.65
EPS 5Y CAGR
8.2%

Cash flow

How much cash the business throws off

Operating CF TTM
$6.95B
Free CF TTM
$5.41B
FCF margin
25.0%

Dividend

Shareholder payout

Yield
0.3%
Payout ratio
19.1%
Last ex-div date
2026-06-17